Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma

Table 6 Univariate analysis of ERCP-related adverse events in patients with and without jaundice, calculated by ERCP sessions

Adverse events		With jaundice^a	Without jaundice	P-value
All adverse events		16.1% (19/118)	16.0% (56/349)	0.989
Pancreatitis	Mild Moderate Severe	7.6% (9/118) 1.7% (2/118) 0.8% (1/118)	5.4% (19/349) 1.1% (4/349) 0.3% (1/349)	0.646
Cholangitis		5.1% (6/118)	8.9% (31/349)	0.187
Cholecystitis		0.8% (1/118)	–	0.085

^aJaundice was defined as a total bilirubin level ≥ 3.0 mg/dL. Cases without data were excluded

ISSN: 1471-230X